Article
EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog.
Journal of cellular physiology - 1 Mar 2002
Kar Siddhartha, Adachi Takahito, Carr Brian I
Abstract excerpt
The K-vitamin analog Cpd 5 or [2-(2-mercaptoethanol)-3-methyl-1,4-napthoquinone] is a potent cell growth inhibitor in vitro and in vivo, likely due to arylation of enzymes containing a catalytic cysteine. This results in inhibition of protein tyrosine phosphatase (PTPase) activity with resultant hyperphosphorylation of EGF receptors (EGFR) and ERK1/2 protein kinases, which are downstream to EGFR in the MAPK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
